The U.S. Food and Drug Administration approved Eisai and Biogen’s application for IV maintenance dosing of lecanemab on January 27. Previously, the label called for biweekly IV dosing. The new ...
President Trump, in one of his first actions back in office, signed an executive order that moves the U.S. government toward designating drug cartels as terrorist organizations. The decision is ...
President Trump, in one of his first actions back in office, signed an executive order that moves the U.S. government toward designating drug cartels as terrorist organizations. The decision is part ...